Moksha Biosurgicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-07-2024
- Paid Up Capital ₹ 5.00 M
as on 10-07-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 25.08 Cr
as on 10-07-2024
- Revenue -21.40%
(FY 2021)
- Profit -47.26%
(FY 2021)
- Ebitda -5.01%
(FY 2021)
- Net Worth 6.12%
(FY 2021)
- Total Assets -6.47%
(FY 2021)
About Moksha Biosurgicals
The Corporate was formerly known as Moksha Biosurgical Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹25.08 Cr.
Ashalata Raut, Sucheta Talati, and Siddharth Talati serve as directors at the Company.
- CIN/LLPIN
U29297MH2006PTC162480
- Company No.
162480
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Moksha Biosurgicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashalata Raut  | Director | 07-Mar-2012 | Current |
| Sucheta Talati | Director | 31-May-2006 | Current |
| Siddharth Talati | Director | 31-May-2007 | Current |
Financial Performance and Corporate Structure Insights of Moksha Biosurgicals.
Moksha Biosurgicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 21.4% decrease. The company also saw a substantial fall in profitability, with a 47.26% decrease in profit. The company's net worth moved up by a moderate rise of 6.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moksha Biosurgicals?
In 2021, Moksha Biosurgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vitrag Biofabs Private LimitedActive 22 years 7 monthsSucheta Talati and Siddharth Talati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jul 2020 | ₹1.98 M | Open |
Others Creation Date: 19 Dec 2019 | ₹1.00 Cr | Open |
Others Creation Date: 20 Nov 2018 | ₹23.88 Cr | Open |
How Many Employees Work at Moksha Biosurgicals?
Unlock and access historical data on people associated with Moksha Biosurgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moksha Biosurgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moksha Biosurgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
